[1] World Health Organization. Global hepatitis report 2017. 2017; https://apps.who.int/iris/handle/10665/255016. Accessed on February 10, 2019. [2] Martínez SM, Crespo G, Navasa M, et al. Noninvasive assessment of liver fibrosis. Hepatology, 2011, 53(1):325-335. [3] Sebastiani G, Ghali P, Wong P, etal. Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey. Can J Gastroenterol Hepatol, 2014, 28(1):23-30. [4] European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol, 2015, 63(1):237-264. [5] Shiha G, Ibrahim A, Helmy A, et al. Asian-Pacific Association for the Study of the Liver (APASL) consensusguidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int, 2017, 11(1):1-30. [6] Rockey DC, Caldwell SH, Goodman ZD, et al. American Association for the Study of Liver D. Liver biopsy. Hepatology, 2009, 49(3):1017-1044. [7] Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology, 2003, 38(2):518-526. [8] Lin ZH, Xin YN, Dong QJ, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology, 2011, 53(3):726-736. [9] Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology, 2006, 43(6):1317-1325. [10] Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patientswith chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology, 2015, 61(1):292-302. [11] Singh S, Muir AJ, Dieterich DT, et al. American Gastroenterological Association Institute technical review on the role of elastography in chronic liver diseases. Gastroenterology, 2017, 152(6):1544-1577. [12] Puigvehí M, Broquetas T, Coll S, et al. Impact of anthropometric features on the applicability and accuracy of FibroScan. J Gastroenterol Hepatol, 2017, 32(10):1746-1753. [13] Wong GL, Wong VW, Chim AM, et al. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J Gastroenterol Hepatol, 2011, 26(2):300-305. [14] Ferraioli G, Parekh P, Levitov AB, et al. Shear wave elastography for evaluation of liver fibrosis. J Ultrasound Med, 2014, 33(2):197-203. [15] 中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015 年版). 实用肝脏病杂志, 2016, 19(3):389-400. [16] 郭欢仪,廖梅,张婷,等. 肝细胞性黄疸对慢性乙型肝炎患者剪切波肝杨氏模量值的影响. 中华超声影像学杂志, 2019, 28(8):680-684. [17] European Association for the Study of the Liver. EASL 201 7 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol, 2017,67(2):370-398. [18] Shiha G, Ibrahim A, Helmy A, et al. Asian-Pacific association for the study of the liver(APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int, 2017, 11(1):1-30. [19] Leung VY, Shen J, Wong VW, et al. Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear wave elastography and transient elastography with liver biopsy correlation. Radiology, 2013, 269(3):910-918. [20] Huang Y, Ding H, Zhang Y, et al. Two-dimensional shear-wave elastography performance in the noninvasive evaluation of liver fibrosis in patients with chronic hepatitis B: comparison with serum fibrosis indexes. Radiology, 2017, 283(3):873-882. [21] Zeng J, Liu GJ, Huang ZP, et al. Diagnostic accuracy of two-dimensional shear wave elastography for the non-invasive staging of hepatic fibrosis in chronic hepatitis B: a cohort study with internal validation. Eur Radiol, 2014, 24 (10):2572-2581. |